Klin Padiatr 2018; 230(03): 172-173
DOI: 10.1055/s-0038-1645015
DOI: 10.1055/s-0038-1645015
Top 5 Cell biology and mechanisms of disease
SMARCB1-Dependencies in Malignant Rhabdoid Tumours: A strategy for Pre-Clinical Therapeutic Target Identification in the Absence of Actionable Mutations
Autor*innen
-
MA Finetti
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
R Ramli
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
J Hacking
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
D Ridgwell
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
MP Selby
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
Y Grabovska
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
A del-Carpio Pons
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
S Batting
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
JA Wood
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
JM Barker
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
A Smith
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
S Crosier
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
P O'Hare
4 Department of Paediatric oncology, Great Ormond Street Hospital NHS trust, London, UK. -
B Pizer
5 Institute of Translational Medicine, University of Liverpool, Liverpool, UK -
B Brennan
6 Royal Manchester Children's Hospital and University of Manchester, Manchester, UK -
S Lowis
7 Royal Hospital for Children and Bristol Medical School, University of Bristol, UK -
D Hargrave
2 Developmental Biology and Cancer Programme, University College London Great Ormond Street Institute of Child Health, London, UK4 Department of Paediatric oncology, Great Ormond Street Hospital NHS trust, London, UK. -
J Anderson
2 Developmental Biology and Cancer Programme, University College London Great Ormond Street Institute of Child Health, London, UK -
TS Jacques
2 Developmental Biology and Cancer Programme, University College London Great Ormond Street Institute of Child Health, London, UK3 Department of Histopathology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK -
S Bailey
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
SC Clifford
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK -
D Williamson
1 Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle Upon Tyne, UK
